Apellis Pharmaceuticals Inc (APLS) — Cash Flow Quality Index
Apellis Pharmaceuticals Inc (APLS) has a Cash Flow Quality Index of -3.27x as of March 2026. Operating cash flow of $-60.97 Million is below net income of $18.66 Million, suggesting accrual-heavy earnings not yet converted to cash. Also explore total assets of Apellis Pharmaceuticals Inc for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Apellis Pharmaceuticals Inc Cash Flow Quality Index (2025–2025)
Historical Cash Flow Quality Index for Apellis Pharmaceuticals Inc across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check APLS intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Apellis Pharmaceuticals Inc (2025–2025)
Year-by-year earnings quality comparison for Apellis Pharmaceuticals Inc. For live market cap and the full company financial profile, see Apellis Pharmaceuticals Inc market cap and net worth.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 2.02x | $45.33 Million | $22.39 Million | — |